食管鳞状细胞癌周围第三类淋巴结构的密度和成熟度预测患者的生存率和对免疫检查点抑制剂的反应。
Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors.
发表日期:2023 Apr 04
作者:
Yoshinori Hayashi, Tomoki Makino, Eiichi Sato, Kenji Ohshima, Yuya Nogi, Takashi Kanemura, Keiichiro Honma, Kotaro Yamashita, Takuro Saito, Koji Tanaka, Kazuyoshi Yamamoto, Tsuyoshi Takahashi, Yukinori Kurokawa, Hiroshi Miyata, Kiyokazu Nakajima, Hisashi Wada, Eiichi Morii, Hidetoshi Eguchi, Yuichiro Doki
来源:
BRITISH JOURNAL OF CANCER
摘要:
第三类淋巴结构(TLSs)是非淋巴组织中的异位淋巴聚集体,与某些癌症类型的良好预后有关。本研究旨在调查TLS在食管癌(EC)中的临床意义。我们在两个不同机构的316个EC手术标本中评估了癌旁TLS的密度和成熟度,使用了苏木精/伊红染色、免疫组化和多重免疫荧光染色。我们分析了TLS与临床病理参数的关联。TLS的临床意义在34例接受抗PD-1抗体治疗的复发EC患者的不同队列中进一步评估。具有高TLS密度的肿瘤主要由成熟TLS组成。高TLS密度与较少晚期肿瘤阶段、无淋巴/血管侵犯、更好的血清营养参数(中性粒细胞计数、白蛋白、中性粒细胞/淋巴细胞比率和预后营养指数)以及延长的生存期显著相关。在成熟TLS病例中,这种生存趋势更为显著,代表了CD138+浆细胞的人口增加。在第二个EC队列中,TLS密度预测临床对抗PD-1抗体的反应和患者的生存率。癌旁TLS的密度和成熟度是预测EC患者长期生存和对抗PD-1抗体治疗反应的有用参数。© 2023年。 作者。
Tertiary lymphoid structures (TLSs) are ectopic lymphoid aggregates in non-lymphoid tissues, which are associated with improved prognosis in some cancer types. This study aimed to investigate the clinical significance of TLSs in oesophageal cancer (EC).In a series of 316 EC surgical specimens from two different institutes, we evaluated the density and maturity of peritumoral TLSs using haematoxylin/eosin, immunohistochemistry, and multiplex immunofluorescence staining. We analysed the association between TLSs and clinicopathological parameters. The clinical significance of TLSs was further evaluated in a different cohort of 34 patients with recurrent EC treated with anti-PD-1 antibody.Tumours with high TLS density predominantly consisted of matured TLSs. High TLS density was significantly associated with less advanced tumour stage, absence of lymphatic/vascular invasion, better serum nutrition parameters (neutrophils count, albumin, neutrophil-to-lymphocyte ratio, and prognostic nutritional index), and prolonged survival. This survival trend was more remarkable in cases with matured TLSs, which represented an increased population of CD138+ plasma cells. In the second EC cohort, TLS density predicted the clinical response to anti-PD-1 antibody and patient survival.The density and maturity of peritumoral TLSs are useful parameters for predicting long-term survival and response to anti-PD-1 antibody treatment in EC patients.© 2023. The Author(s).